# A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer

> **NCT00557037** · PHASE2 · COMPLETED · sponsor: **MEI Pharma, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Phenoxodiol

## Key facts

- **NCT ID:** NCT00557037
- **Lead sponsor:** MEI Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2009-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557037, "A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00557037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*